TRACON Pharmaceuticals, Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8912a3d9-577b-42b6-8a23-dfc402c6ab24/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $12.0M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-026205 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001564590-23-003313 |
| FY 2021 | $346.0k | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010475 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008957 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007520 |
| FY 2018 | $3.0M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005597 |
| FY 2017 | $8.8M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-005597 |
| FY 2016 | $3.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-005597 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TRACON Pharmaceuticals, Inc. — all facts · Net Income · Operating Income